Advertisement

Topics

P.A.L.M. Microlaser Technologies GmbH Company Profile

12:39 EST 12th December 2018 | BioPortfolio

P.A.L.M. Microlaser Technologies GmbH is the world leader in non-contact microdissection and micromanipulation systems using the patented LMPC-technology (Laser Microdissection and Pressure Catapulting).P.A.L.M. has been able to create a platform for a key technology serving medical, biological and pharmaceutical research. This was only possible with the modular concept of the PALM MicroLaser Systems, tailor-made accessories and consumables and high quality scientific support by our Application Laboratory.
The company was founded in 1993 by Dr. Karin Schütze and her husband Raimund Schütze. From its location near Munich/ Germany the PALM MicroLaser Systems have been spread around the world and have gained a well-known reputation.
In 2001 Karin and Raimund Schütze were honored with the Philip Morris research award for the development of marketable micromanipulation systems.
Creative innovations combined with the potential of an international established organization resulted in the integration of P.A.L.M. into Carl Zeiss in December 2004. Since March 1st, 2006 P.A.L.M. is a 100% subsidiary of the Carl Zeiss MicroImaging GmbH.
Also in the future P.A.L.M. Microlaser Technologies will stand for highest competence in Technology and Service in all fields of microdissection and micromanipulation

Location

Am Neuland 9 + 12
Bernried
82347
Germany

Contact

Phone: 49 (0) 8158 9971 0
Fax: 49 (0) 8158 9971 249
Email: info@palm-microlaser.com


News Articles [434 Associated News Articles listed on BioPortfolio]

Company Profile for JPT Peptide Technologies GmbH

JPT Peptide Technologies is a DIN ISO 9001:2015 certified provider of innovative high quality peptide-based products and services such as clinical grade peptides & pools, cust...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Global Zero Liquid Discharge Systems Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

JA Solar dodáva poločlánkové moduly pre solárne elektrárne v Afrike

Spolutvorcami projektu v Namíbii sú renomovaný nemecký developer SunEQ GmbH, sesterská spoločnosť konzultačnej firmy pre obnoviteľné zdroje energie Suntrace GmbH a popredný nový dodáva...

PubMed Articles [332 Associated PubMed Articles listed on BioPortfolio]

Adoption of Stroke Rehabilitation Technologies by the User Community: Qualitative Study.

Using technology in stroke rehabilitation is attractive. Devices such as robots or smartphones can help deliver evidence-based levels of practice intensity and automated feedback without additional la...

Application of Digital Technologies in Maxillofacial Prosthetics Literature: A 10-Year Observation of Five Selected Prosthodontics Journals.

To identify trends in the application of various types of digital technologies in maxillofacial prosthetics by identifying these digital technologies and their characteristics and reviewing the preval...

What do we know about technologies for dementia-related wandering? A scoping review: Examen de la portée : Que savons-nous à propos des technologies de gestion de l'errance liée à la démence?

Occupational therapists use technologies to manage wandering-related risks to promote safety and independence among individuals with dementia living in the community.

Graphics and Media Technologies for Operators in Industry 4.0.

Visual computing technologies have an important role in manufacturing and production, particularly in new Industry 4.0 scenarios with intelligent machines, human-robot collaboration and learning facto...

Nurse and Nurse Student Attitudes and Perceived Self-efficacy in Use of Information and Communication Technologies: Professional and Cultural Differences.

Information and communication technologies have become essential and design-effective tools in the global healthcare system. Evidence suggests that information and communication technologies can promo...

Clinical Trials [505 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [1814 Associated Companies listed on BioPortfolio]

P.A.L.M. Microlaser Technologies GmbH

P.A.L.M. Microlaser Technologies GmbH is the world leader in non-contact microdissection and micromanipulation systems using the patented LMPC-technology (Laser Microdissection and Pressure Catapultin...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

GYMWATCH GmbH

GYMWATCH GmbH develops advanced fitness technologies and devices. Based in Darmstadt, Germany, near Frankfurt, the company’s first product is the patented GYMWATCH Sensor, wh...

More Information about "P.A.L.M. Microlaser Technologies GmbH" on BioPortfolio

We have published hundreds of P.A.L.M. Microlaser Technologies GmbH news stories on BioPortfolio along with dozens of P.A.L.M. Microlaser Technologies GmbH Clinical Trials and PubMed Articles about P.A.L.M. Microlaser Technologies GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of P.A.L.M. Microlaser Technologies GmbH Companies in our database. You can also find out about relevant P.A.L.M. Microlaser Technologies GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record